GENZYME - THE KING OF THE BIOTECHS Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GENZYME - THE KING OF THE BIOTECHS

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aliveinsf who wrote (279)	7/16/1998 10:18:00 AM
From: Caveat Emptor	Read Replies (1) of 410

Major Insider Profit Taking-7/97-1/98 I looked at the insider trading report posted 7/14 on Yahoo board. It is disturbing in the fact that certain executives and officers of Genzyme sold significant stock positions for millions of dollars between 8/97 and 1/98. ie: Alan E. Smith - Sr. VP Research - over 30,000 shares sold (not including options) - Over $900,000.00 total David D. Fleming-Group VP Diagnostic Products-Over 47,000 shares sold (no including options) - Over $1.2 Million total John Heffernan- Sr. VP Human Resources-Over 82,000 shares sold (not inlcuding options) - Over $2.4 Million The stock struggles though this period of time... also, this is the period of time where the Units of PArtnerships were being transferred around. Any comments about this profit taking? CAVEAT EMPTOR

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next